Abstract
Human cancers are consequence of mutations in genes that encode proteins involved in the control of cellular homeostasis. Most human cancers are sporadic and gene mutations may be induced by a large number of environmental agents. Cell response to carcinogens is regulated by genes involved in liver metabolism. Variability in liver metabolism has been associated with polymorphisms in genes that code for phase I and phase II detoxification enzymes. These polymorphisms are relatively common in the population and may be associated with a higher risk of developing cancer. Moreover, as carcinogens act inducing changes in the DNA, there is a link between DNA repair genes and cancer susceptibility, such that mutations in these genes are associated with cancer susceptibility. Finally, oncogenes and tumor suppressor genes also can present allelic variants that are not directly imply in cancer development but can modify individual susceptibility to cancer. Here we review the most frequent polymorphisms described in genes involved in carcinogen metabolism, DNA repair and in oncogenes and tumor suppressor genes that have been associated with modification in cancer susceptibility.
Keywords: carcinogen, carcinogen metabolism, oncogene, tumor suppressor gene
Current Genomics
Title: Genetics of Cancer Susceptibility
Volume: 3 Issue: 4
Author(s): Rogelio Gonzalez-Sarmiento
Affiliation:
Keywords: carcinogen, carcinogen metabolism, oncogene, tumor suppressor gene
Abstract: Human cancers are consequence of mutations in genes that encode proteins involved in the control of cellular homeostasis. Most human cancers are sporadic and gene mutations may be induced by a large number of environmental agents. Cell response to carcinogens is regulated by genes involved in liver metabolism. Variability in liver metabolism has been associated with polymorphisms in genes that code for phase I and phase II detoxification enzymes. These polymorphisms are relatively common in the population and may be associated with a higher risk of developing cancer. Moreover, as carcinogens act inducing changes in the DNA, there is a link between DNA repair genes and cancer susceptibility, such that mutations in these genes are associated with cancer susceptibility. Finally, oncogenes and tumor suppressor genes also can present allelic variants that are not directly imply in cancer development but can modify individual susceptibility to cancer. Here we review the most frequent polymorphisms described in genes involved in carcinogen metabolism, DNA repair and in oncogenes and tumor suppressor genes that have been associated with modification in cancer susceptibility.
Export Options
About this article
Cite this article as:
Gonzalez-Sarmiento Rogelio, Genetics of Cancer Susceptibility, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350435
DOI https://dx.doi.org/10.2174/1389202023350435 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metallodrug Conjugates with Steroids and Selective Estrogen Receptor Modulators (SERM)
Current Medicinal Chemistry Sex Steroid Hormone Effects in Normal and Pathologic Conditions in Lung Physiology
Mini-Reviews in Medicinal Chemistry The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
Current Pharmaceutical Design Hypoxia and Fetal Heart Development
Current Molecular Medicine Cinnamic Acid Derivatives as Anticancer Agents-A Review
Current Medicinal Chemistry Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators
Current Medicinal Chemistry Cardiovascular Effects of the Phytoestrogen Genistein
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line
Current Pharmaceutical Biotechnology Application of Reproductive Hormone Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Epigenetic Regulators Governing Cancer Stem Cells and Epithelial- Mesenchymal Transition in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Glucose Transporters in Sex Steroid Hormone Related Cancer
Current Vascular Pharmacology The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia
Current Medicinal Chemistry Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors
Current Cancer Therapy Reviews Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology Expression and Function of Angiomodulating Cytokines in Rheumatoid Arthritis and Experimental Arthritis: Important Therapeutic Targets
Current Immunology Reviews (Discontinued) mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry The Targets of Curcumin
Current Drug Targets Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors
Letters in Drug Design & Discovery